Giant cell tumor of the sphenoid bone: a systematic literature review with illustrative cases

Giant cell tumors (GCTs) of the bone are typically benign but locally aggressive tumors usually affecting the long bones of young adults. Rarely, these tumors may arise in the skull, most often involving the sphenoid or temporal bones. Here, we performed a systematic literature review and identified 79 previously reported cases of GCTs of the sphenoid bone, and we added two illustrative cases of patients affected by this condition. The first patient, a 22-year-old woman, was treated with surgery and radiotherapy and has been followed up for 17 years without evidence of tumor recurrence. The second patient has been seen recently and was treated with two successive surgeries. These tumors usually occur between the second and the third decade of life and are more prevalent in women. Symptoms leading to diagnosis are related to local mass effect and include headache, third and sixth cranial nerve palsy, impaired facial sensitivity, diplopia, and decreased vision, and clinical manifestations of endocrine dysfunction may also be present. Imaging techniques usually depict an osteolytic lesion of the sphenoid bone extending to adjacent anatomical structures. Differential diagnoses include invasive pituitary adenomas, chordomas, chondrosarcomas, brown tumors, and giant cell reparative granulomas. The diagnosis is confirmed histologically, characterized by numerous osteoclast-like multinucleated giant cells, mononuclear cells, and stromal cells, the latter showing histone H3 G34W/R/V mutations on immunohistochemistry. Transsphenoidal surgery remains the first-line treatment, while radiotherapy or denosumab may be considered in cases of residual, progressive, or recurrent disease.

Authors

Institutions

Publication Details

Journal
Endocrine Related Cancer
Published
2026-02-12
DOI
https://doi.org/10.1530/erc-24-0289
Primary Topic
Bone Tumor Diagnosis and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Giant cell tumor of the sphenoid bone: a systematic literature review with illustrative cases

Sylvie Salenave, Luigi Maione, P. Kamenicky, M. Bouchaala et al.
Endocrine Related Cancer
Bone Tumor Diagnosis and Treatments
article

Giant cell tumor of the sphenoid bone: a systematic literature review with illustrative cases

Sylvie Salenave, Luigi Maione, P. Kamenicky, M. Bouchaala, Jacques Young, Fanny Chasseloup, Tatiana Lecot-Connan, Matthias Babin, Clovis Adam, Etienne Lefevre
article en

Abstract

Giant cell tumors (GCTs) of the bone are typically benign but locally aggressive tumors usually affecting the long bones of young adults. Rarely, these tumors may arise in the skull, most often involving the sphenoid or temporal bones. Here, we performed a systematic literature review and identified 79 previously reported cases of GCTs of the sphenoid bone, and we added two illustrative cases of patients affected by this condition. The first patient, a 22-year-old woman, was treated with surgery and radiotherapy and has been followed up for 17 years without evidence of tumor recurrence. The second patient has been seen recently and was treated with two successive surgeries. These tumors usually occur between the second and the third decade of life and are more prevalent in women. Symptoms leading to diagnosis are related to local mass effect and include headache, third and sixth cranial nerve palsy, impaired facial sensitivity, diplopia, and decreased vision, and clinical manifestations of endocrine dysfunction may also be present. Imaging techniques usually depict an osteolytic lesion of the sphenoid bone extending to adjacent anatomical structures. Differential diagnoses include invasive pituitary adenomas, chordomas, chondrosarcomas, brown tumors, and giant cell reparative granulomas. The diagnosis is confirmed histologically, characterized by numerous osteoclast-like multinucleated giant cells, mononuclear cells, and stromal cells, the latter showing histone H3 G34W/R/V mutations on immunohistochemistry. Transsphenoidal surgery remains the first-line treatment, while radiotherapy or denosumab may be considered in cases of residual, progressive, or recurrent disease.

Endocrine Related CancerVol. 33(3)
Inserm (FR), Université Paris-Saclay (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Pitié-Salpêtrière Hospital (FR), Bicêtre Hospital (FR)
Good health and well-being
Openalex Percentile: Top 58%
Bone Tumor Diagnosis and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.